Poland· PL-100270676
Nodom
A dorzolamide product containing dorzolamidum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dorzolamide is registered in 19 of 19 countries.
Countries holding a registration under ATC S01EC03 (dorzolamide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Dorzolamide · ATC S01EC03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Dorzolamidum
- Manufacturer
- Zakłady Farmaceutyczne POLPHARMA S.A.
- Country
- Poland (PL)
- ATC code
- S01EC03
- ATC class
- Dorzolamide
- Defined daily dose
- 0.3 ml, AT
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
2 priced- gtin059099909428551 but.po 5 mlPLN 23
- gtin059002571010153 but.po 5 mlPLN 54.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for dorzolamide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dorzolamide · interactions on record
4 records
- 4 severe
Most severe, free to view
- Acetylsalicylic acidB01AC06severe
- Salicylic acidD01AE12severe
- Acetylsalicylic acidN02BA01severe
- Salicylic acidS01BC08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dorzolamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDORZOLAMID OLIKLAOlikla s.r.o., Kostelec nad Černými Lesy
- United StatesDorzolamide HClBausch & Lomb Incorporated
- FinlandAikumSanoSwiss UAB
- BelgiumCosopt 20 mg/ml - 5 mg/mlPI Pharma
- NetherlandsDorzolamide Aurobindo 20 mg/ml oogdruppels, oplossingAurobindo Pharma B.V.
- SwedenDimaz 20 mg/ml Ögondroppar, lösningZaklady Farmaceutyczne Polpharma SA
- FranceDORZOLAMIDE BGR 20 mg/ml, collyre en solutionBIOGARAN
- NorwayDorzolamid al compAliud Pharma
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Dorlazept, Dorzo-Vision
- Belgium · Trusopt, Trusopt 2 % Unit Dose
- Bulgaria · Дорзамед
- Cyprus · Dorolad, Dorzon
- Czechia · Dorzolamid Olikla, Dorzolamide Farmaprojects
- Germany · Dimaz, Dorlazept
- Denmark · Delazo, Dorzolamid Hexal
- Estonia · Dorzolamide Elvim, Trusopt
- Spain · Arzolan, Dimaz
- Finland · Itoco, Odyral
- France · Dorzolamide Arrow, Dorzolamide Bgr
- United Kingdom (Northern Ireland) · Dimaz, Dorzolamide
- Greece · Delazo, Dorolad
- Croatia · Dorvis, Dorzol
- Hungary · Dorzolep, Trusopt
- Ireland · Itoco, Trusopt
- Iceland · Dorzolamide Alvogen
- Italy · Dorzoclar, Dorzolamide Aurobindo
- Lithuania · Dorzolamide Actavis, Dorzolamide Elvim
- Luxembourg · Dorzo-Vision, Trusopt 2 % Unit Dose
- Latvia · Dorzolamide Actavis, Dorzolamide Elvim
- Netherlands · Dorzolamide Hydrochloride Aurobindo, Dorzolamide Viatris
- Norway · Dimaz, Trusopt
- Portugal · Dimaz, Dorcil
- Romania · Dorzolamidă Arena, Dorzopt
- Sweden · Dimaz, Dorzolamid Hexal
- Slovakia · Dorzolamid Olikla, Dozotens
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb44233f-e324-4fa1-ba58-b4638fd771a0 GET /v1/drugs/bb44233f-e324-4fa1-ba58-b4638fd771a0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "20 mg/ml",
"packaging": "05909990942855 ¦ Rp ¦ 73361\n1 butelka 5 ml\n05900257101015 ¦ Rp ¦ 120019\n3 butelki 5 ml",
"substance": "Dorzolamidi hydrochloridum 22.26 mg/ml",
"common_name": "Dorzolamidum",
"pl_product_id": "100270676",
"pozwolenie_nr": "19714",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about dorzolamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.